Mountain States Tumor Institute at St. Luke's Regional Medical Center

Name:	Mountain States Tumor Institute at St. Luke's Regional Medical Center
Phone:	Click to View Phone #

Location

Mountain States Tumor Institute at St. Luke's Regional Medical Center
Boise, Idaho 83712

Trials at this Location

Name	City	State	Zip
Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy	Boise	ID	83712
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer	Boise	ID	83712
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin	Boise	ID	83712
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer	Boise	ID	83712
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma	Boise	ID	83712
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	Boise	ID	83712
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy	Boise	ID	83712
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Boise	ID	83712
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Boise	ID	83712
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors	Boise	ID	83712
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma	Boise	ID	83712
Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma	Boise	ID	83712
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors	Boise	ID	83712
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	Boise	ID	83712
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma	Boise	ID	83712
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	Boise	ID	83712
Collecting and Storing Tissue From Young Patients With Cancer	Boise	ID	83712
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Boise	ID	83712
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Boise	ID	83712
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor	Boise	ID	83712
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma	Boise	ID	83712
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma	Boise	ID	83712
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes	Boise	ID	83712
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	Boise	ID	83712
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer	Boise	ID	83712
Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia	Boise	ID	83712
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma	Boise	ID	83712
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor	Boise	ID	83712
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors	Boise	ID	83712
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Boise	ID	83712
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma	Boise	ID	83712
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer	Boise	ID	83712
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma	Boise	ID	83712
High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer	Boise	ID	83712
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia	Boise	ID	83712
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies	Boise	ID	83712
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Boise	ID	83712
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma	Boise	ID	83712
Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)	Boise	ID	83712
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Boise	ID	83712
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Boise	ID	83712
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Boise	ID	83712
PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma	Boise	ID	83712
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Boise	ID	83712
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia	Boise	ID	83712
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Boise	ID	83712
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Boise	ID	83712
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer	Boise	ID	83712
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy	Boise	ID	83712
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy	Boise	ID	83712
Study of Blood Samples From Newborns With Down Syndrome	Boise	ID	83712
Study of Kidney Tumors in Young Patients	Boise	ID	83712
Study of Late-Occurring Complications in Childhood Cancer Survivors	Boise	ID	83712
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Boise	ID	83712
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms Tumor	Boise	ID	83712

advanced trial search

Condition:
Zip:
Radius:

Age:

to

Phase:
Healthy volunteer:
Yes No

helpful resources

share this page

Mountain States Tumor Institute at St. Luke's Regional Medical Center | Boise, Idaho

Trials at this Location